Incidence, predictors, and long term clinical outcome of angiographic definite stent thrombosis in real world scenario - A prospective cohort study
Autor: | Naved Aslam, Bhupinder Singh, Abhishek Goyal, Gurpreet Singh Wander, Basvappa Ramesh, Shibba Takkar Chhabra, Bishav Mohan, Vivek Singla, Manjunath Cholenhally Nanjappa, Yadvinder Singh, Vikram B Kolhari, Ravindran Rajendran |
---|---|
Rok vydání: | 2017 |
Předmět: |
Bare-metal stent
Male medicine.medical_specialty Acute coronary syndrome Time Factors medicine.medical_treatment Shock Cardiogenic India 030204 cardiovascular system & hematology Coronary Angiography 03 medical and health sciences 0302 clinical medicine Percutaneous Coronary Intervention Predictive Value of Tests Risk Factors Internal medicine medicine Humans cardiovascular diseases 030212 general & internal medicine Myocardial infarction Prospective Studies Prospective cohort study Aged business.industry Coronary Thrombosis Incidence Stent Percutaneous coronary intervention Drug-Eluting Stents General Medicine Middle Aged medicine.disease surgical procedures operative Treatment Outcome Drug-eluting stent Cardiology ST Elevation Myocardial Infarction Female Stents Cardiology and Cardiovascular Medicine business TIMI |
Zdroj: | Cardiovascular revascularization medicine : including molecular interventions. 19(6) |
ISSN: | 1878-0938 |
Popis: | Background The occurrence of stent thrombosis (ST) in real world scenario is far different from that mentioned in the literature. Our study identifies the various parameters of ST. Methods This is a prospective observational-cohort study where-in consecutive patients who received successful percutaneous transluminal angioplasty (PTCA) over the study period of 1-year was included and were followed for 1-year from the primary procedure. Results The overall incidence of definite ST was 1.4% and 1.7% at 30 days and 1 year respectively. The most common mode of presentation of ST was ST-elevation myocardial infarction (82.6%). The history of prior PTCA, multi-vessel disease, emergent PTCA, acute coronary syndrome and type B2/C lesions were found to be the independent predictors for definite ST. The incidence of late ST was significantly higher with bare metal stent (BMS) than drug-eluting stent (DES) (OR-2.4, 95% CI:1.3–4.5). At mean follow-up of 13.9 months after ST, the overall mortality was 36.9%. The independent predictors of mortality after ST were post-PTCA thrombolysis in myocardial infarction (TIMI) flow grade cardiogenic shock at the time of presentation. Conclusion The overall incidence of definite ST is high in the real world scenario and the DES fared better than BMS. ST carries a bad prognosis especially so if the patients present in cardiogenic shock, or unable to achieve TIMI-3 flow after PTCA. |
Databáze: | OpenAIRE |
Externí odkaz: |